Research use only: difference between revisions
Diff·revision 7 → 8·05:43, 23 Sep 2024
Difference between revision 7 and revision 8 of Research use only. 6 lines changed; the page grew by 334 bytes.
| Revision 7 — 18:59, 13 Sep 2024 CagriCass (talk) split the compounding position from the manufacturing position 3,193 bytes +314 | Revision 8 — 05:43, 23 Sep 2024 LabelLibby (talk) add category for drug regulation 3,527 bytes +334 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Research use only | 2 | | name = Research use only |
| + | 3 | <!-- Identification --> | |
| + | 4 | | Abbreviation = RUO | |
| + | 5 | | Applied by = The seller | |
| + | 6 | | Assessed by = No authority | |
| 3 | }} | 7 | }} |
| 4 | 8 | ||
| ⋮ | ⋮ | ||
| 18 | * '''No pharmacovigilance.''' There is no adverse-event reporting route, so no signal accumulates anywhere. | 22 | * '''No pharmacovigilance.''' There is no adverse-event reporting route, so no signal accumulates anywhere. |
| 19 | * '''No labelling standard.''' Strength, fill convention and storage statements follow no prescribed form; see the discussion of nominal fill at [[Peptide content]]. | 23 | * '''No labelling standard.''' Strength, fill convention and storage statements follow no prescribed form; see the discussion of nominal fill at [[Peptide content]]. |
| + | 24 | ||
| + | 25 | {{warn|Material described anywhere on this wiki as research-use-only is not approved for human use. PeptidePedia describes what is documented about such material; it does not advise on its use, and nothing here is medical advice.}} | |
| 20 | 26 | ||
| 21 | == References == | 27 | == References == |